Is effective management of CLL as a chronic disease as good as a ‘”cure”?

Arnon Kater

Arnon Kater, MD, PhD from the University of Amsterdam, Amsterdam, Netherlands discusses the concept of developing a cure for chronic lymphocytic leukemia (CLL). Prof. Arnon describes the risks often involved with procedures such as allogeneic transplants performed to “cure” patients. As an alternative, using new, available drugs to make CLL a truly chronic disease that can be controlled, is not only achievable but can allow the patients to have a good quality of life. This interview was recorded at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 held in New York, NY.

Share this video